A Study to Evaluate the Efficacy and Safety of AK102 Q6W in Patients With Hyperlipidemia
Clinical trial NCT05260411 · COMPLETED
Trial details
- NCT number
- NCT05260411
- Sponsor
- Akeso
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2022-01-26
- Primary completion
- 2022-12-19
- Enrollment
- 246
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.